Tagged With diabetes

2

Since launching in 2011, Silicon Valley healthcare startup Sano Intelligence has kept a low profile. Despite raising $US20 million ($26 million) in venture capital, the company founded by ex-Bain Capital analyst and bioengineering grad Ashwin Pushpala has yet to release its product — a continuous glucose tracker that sticks to a users' skin and monitors blood through an app. Gizmodo has obtained new details about the device, and how the company intends to market it as a product for "metabolic insight" for non-diabetics, rather than to diabetics who regularly need to track their glucose. The strategy means Sano doesn't need FDA approval in the US, but doctors and diabetes experts interviewed by Gizmodo question whether the product would have any benefits to non-diabetics at all.

5

An analysis by Tufts University researchers has failed to find a link between butter consumption and cardiovascular disease. And hallelujah to that — the ongoing hysteria against butter can now finally come to an end.

1

For years, assistance dogs have been used to detect low blood sugar levels in their diabetic owners and warn of an impending hypoglycemia attack. Scientists have finally figured out how dogs are able to accomplish this feat — an insight that could lead to new medical sensors.

1

Australian scientists have shown that brown fat — a special type of fat that burns energy to produce heat — may also help to keep blood sugar steady in adults. Researchers at Sydney’s Garvan Institute of Medical Research measured brown fat activity and blood glucose continuously in real time in study participants, and found that individuals with more brown fat had smaller fluctuations in blood sugar.

Their findings open new avenues for diabetes therapies that target brown fat.

1

Stanford researchers recently published work on a small microchip they have developed that scans for diabetes in a fraction of the time of current tests. Additionally, their test is reusable for upwards of 15 patients, can be performed on site, and is more accurate in differentiating the biomarkers that distinguish type 1 and type 2 diabetes. In other words, it's a major milestone in diabetes research.

1

Whether you don't like needles, or whether you really don't like needles, there's some good news on the horizon: a special "bioadhesive" coating that was just developed at Brown University is bringing us one step closer to saying goodbye to injections and hello to things like insulin pills.